Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection versus isosorbide dinitrate ointment for chronic anal fissure
NL-OMON22742Active, not recruiting
- Start
- Jun 2002
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic anal fissure (CAF) comparing Botulinum toxin type A injection arm with Isosorbide dinitrate ointment arm (2 arms). Primary endpoint: Macroscopic healing of the fissure. Started Jun 2002; status: active, not recruiting.
02
Drugs
botulinum toxin type Aisosorbide dinitrate
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NL-OMON22742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22742.